Editorial: Rethinking the definition of diabetes for precision medicine

Molecular Endocrinology

Volumn 29, Issue 3, 2015, Pages 335-337

  Ahima, Rexford S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIABETES MELLITUS; EDITORIAL; HEALTH CARE COST; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MEDICAL INFORMATICS; MEDICINE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PRECISION MEDICINE; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PERSONALIZED MEDICINE;

DIABETES MELLITUS; HUMANS; PRECISION MEDICINE;

EID: 84923647728     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2015-1037     Document Type: Editorial

References (15)

1. http://dels.nas.edu/Report/Toward-Precision-Medicine-BuildingKnowledge/13284. Accessed February 2, 2015.
2. Mirnezami R, Nicholson J, Darzi A. Preparing for precision medicine. N Engl J Med. 2012;366:489–491.
3. Hamburg MA, Collins FS. The path to personalized medicine. N Engl J Med. [Erratum 2010;363:1092] 2010;363:301–304.
4. Mega JL, Sabatine MS, Antman EM. Population and personalized medicine in the modern era. JAMA. 2014;312:1969–1970.
5. http://www.whitehouse.gov/blog/2015/01/21/precision-medicineimprovinghealth-and-treating-disease. Accessed February 2, 2015.
6. http://www.whitehouse.gov/the-press-office/2015/01/30/fact-sheetpresident-obama-s-precision-medicine-initiative. Accessed February 2, 2015.
7. http://www.who.int/diabetes/facts/en/. Accessed February 2, 2015.
8. Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Atlanta: US Department of Health and Human Services; 2014.
9. American Diabetes Association. Economic costs of diabetes in the US in 2012. Diabetes Care. 2013;36:1033–1046.
10. McCarthy MI. Genomics, type 2 diabetes, and obesity. N Engl J Med. 2010;363:2339–2350.
11. Stolar MW. Defining and achieving treatment success in patients with type 2 diabetes mellitus. Mayo Clin Proc. 2010;85(12): S50–S59.
12. Brown A, Reynolds LR, Bruemmer D. Intensive glycemic control and cardiovascular disease: an update. Nat Rev Cardiol. 2010;7: 369–375.
13. Zoungas S, Chalmers J, Neal B, et al. ADVANCE-ON Collaborative Group. Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med. 2014;371:1392–1406.
14. Zoungas S, Patel A, Chalmers J, et al. ADVANCE Collaborative Group. Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010;363:1410–1418.
15. Cefalu WT, Petersen MP, Ratner RE. The alarming and rising costs of diabetes and prediabetes: a call for action! Diabetes Care. 2014; 37:3137–3138.